Clinical Trials Directory

Trials / Terminated

TerminatedNCT03475797

Evaluation of Occipital Nerve Stimulation in Intractable Occipital Neuralgias

Evaluation of Occipital Nerve Stimulation in Intractable Occipital Neuralgias: a Multicentric, Controlled, Randomized Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Medically intractable pain caused by occipital neuralgia can be very difficult to control with traditional pain management. Peripheral nerve stimulation which is used in migraines and cluster headache can be an alternative for these patients with occipital neuralgias when medical treatment and traditional pain management have failed (drugs for neuropathic pain, infiltrations, psychobehavioral approaches and multidisciplinary approach in a pain center). Occipital nerve stimulation consists to put a lead subcutaneously in front of the occipital nerve and to connect the lead to a pulse generator. A retrospective study of 60 patients was conducted in Nantes University Hospital. The results were good with the Visual Analog Scale (VAS) decreased from 8.4 preoperatively to 2.85 postoperatively. The medical quantification scale (MQS) was reduced to about 50% (18 preoperatively versus 9.9 postoperatively). Stimulation was quiet stable over time with a mean follow-up of 24 months (range 6 to 72 months). The aim of StimO is to confirm this result through a national controlled randomized multicenter study where occipital nerve stimulation will be compared to the optimal medical management.

Conditions

Interventions

TypeNameDescription
DEVICEOccipital nerve stimulationOccipital nerve stimulation with percutaneous or surgical lead
OTHEROptimal Medical ManagementOptimal Medical Management according to what is done in routine clinical practice : drug, psychobehavioral approach, acupuncture, sophrology, etc.

Timeline

Start date
2018-04-20
Primary completion
2021-06-26
Completion
2021-09-03
First posted
2018-03-23
Last updated
2021-10-11

Locations

10 sites across 1 country: France

Source: ClinicalTrials.gov record NCT03475797. Inclusion in this directory is not an endorsement.